UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Cousins Properties
CUZ
$5.06B
| $18.2M | ﹤0.01% |
594,841
+415,725
| +232% | +$12.8M |
|
2427
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $18.2M | ﹤0.01% |
757,474
+64,314
| +9% | +$1.56M |
|
2428
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $18.2M | ﹤0.01% |
684,200
-41,079
| -6% | -$1.16M |
|
2429
PUT
Darden Restaurants
DRI
$23.9B
| $18.2M | ﹤0.01% |
97,500
-59,100
| -38% | -$9.91M |
|
2430
Park National Corp
PRK
$3.75B
| $18.2M | ﹤0.01% |
106,048
+92,405
| +677% | +$16.7M |
|
2431
Tennant Co
TNC
$1.49B
| $18.2M | ﹤0.01% |
222,916
+186,693
| +515% | +$16.4M |
|
2432
Choice Hotels
CHH
$5.09B
| $18.2M | ﹤0.01% |
127,894
+88,753
| +227% | +$12.6M |
|
2433
Valley National Bancorp
VLY
$8.17B
| $18.2M | ﹤0.01% |
2,003,862
+1,332,182
| +198% | +$12.9M |
|
2434
Invesco S&P MidCap Low Volatility ETF
XMLV
$747M
| $18.2M | ﹤0.01% |
298,439
-13,235
| -4% | -$827K |
|
2435
CALL
Amgen
AMGN
$220B
| $18.1M | ﹤0.01% |
69,600
-80,100
| -54% | -$23.8M |
|
2436
FTI Consulting
FCN
$4.23B
| $18.1M | ﹤0.01% |
94,821
+81,670
| +621% | +$16.8M |
|
2437
BlackRock Health Sciences Trust II
BMEZ
$976M
| $18.1M | ﹤0.01% |
1,257,133
-155,991
| -11% | -$2.41M |
|
2438
CALL
Illumina
ILMN
$30.2B
| $18M | ﹤0.01% |
135,000
+109,000
| +419% | +$15.5M |
|
2439
CALL
Okta
OKTA
$25.6B
| $18M | ﹤0.01% |
228,800
+44,200
| +24% | +$3.43M |
|
2440
Qfin Holdings
QFIN
$1.6B
| $18M | ﹤0.01% |
469,695
+280,305
| +148% | +$9.7M |
|
2441
Bentley Systems
BSY
$10.9B
| $18M | ﹤0.01% |
385,620
+260,181
| +207% | +$12.7M |
|
2442
PUT
Tenet Healthcare
THC
$21.1B
| $18M | ﹤0.01% |
142,600
+10,100
| +8% | +$1.5M |
|
2443
CALL
Nucor
NUE
$62.6B
| $18M | ﹤0.01% |
154,000
-69,500
| -31% | -$10M |
|
|
CNTA
2444
DELISTED
Centessa Pharmaceuticals
CNTA
| $17.9M | ﹤0.01% |
1,070,209
+1,065,202
| +21,274% | +$17.6M |
|
|
TWO
2445
Two Harbors Investment
TWO
$1.26B
| $17.9M | ﹤0.01% |
1,513,679
+1,021,126
| +207% | +$12.4M |
|
|
DLY
2446
DoubleLine Yield Opportunities Fund
DLY
$682M
| $17.9M | ﹤0.01% |
1,131,082
+11,214
| +1% | +$182K |
|
2447
Payoneer
PAYO
$2.41B
| $17.9M | ﹤0.01% |
1,780,197
+578,130
| +48% | +$5.52M |
|
2448
TriNet
TNET
$3.14B
| $17.8M | ﹤0.01% |
196,461
+177,698
| +947% | +$16.4M |
|
2449
PUT
NetApp
NTAP
$36.6B
| $17.8M | ﹤0.01% |
153,600
| – | – |
|
2450
iShares MSCI Canada ETF
EWC
$6.27B
| $17.8M | ﹤0.01% |
442,412
-5,891
| -1% | -$246K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.